文献速递神经肿瘤

用于预测间变性星形细胞瘤患者总生存期与肿瘤特异性生存期的实用列线图及风险分层系统

Practical Nomograms and Risk Stratification System for Predicting the Overall and Cancer-specific Survival in Patients with Anaplastic Astrocytoma.
PubMed 文献 · World Neurosurg · 2024-06-21

研究基于监测、流行病学和最终结果数据库2004至2015年诊断的2997例间变性星形细胞瘤患者,回顾性提取数据,用最小绝对收缩和选择算子及多因素Cox回归建立总生存期与肿瘤特异性生存期列线图,并按70%与30%分为训练队列(2097例)和验证队列(900例),列线图一致性指数分别为0.752(95%CI:0.741-0.764)和0.753(95%CI:0.741-0.765),并据此建立高低风险分层系统。

要点

  • 年龄、家庭收入、肿瘤部位、扩展范围、手术、放疗和化疗是总生存期与肿瘤特异性生存期的独立预后因素。
  • 训练队列中总生存期列线图一致性指数为0.752(95%CI:0.741-0.764),肿瘤特异性生存期为0.753(95%CI:0.741-0.765)。
  • 基于列线图将患者分为高风险与低风险组,构建了总生存期和肿瘤特异性生存期的风险分层系统。

核心结论

  • 构建了两个预测列线图及风险分层系统,可有效预测间变性星形细胞瘤患者的总生存期和肿瘤特异性生存期率。
  • 这些模型经内部验证具有相当准确性和可靠性,可能有助于未来临床实践。

研究设计与样本

  • 基于人群的队列研究,回顾性提取监测、流行病学和最终结果数据库中2004年至2015年诊断的2997例间变性星形细胞瘤患者数据。
  • 采用最小绝对收缩和选择算子及多因素Cox回归分析筛选因素并建立预后列线图。
  • 患者按70%与30%分为训练队列(2097例)和验证队列(900例)。
  • 用一致性指数和受试者工作特征曲线评估列线图区分能力,并基于列线图建立风险分层。

主要发现

  • 年龄、家庭收入、肿瘤部位、扩展范围、手术、放疗和化疗被确定为总生存期和肿瘤特异性生存期的独立预后因素。
  • 训练队列中总生存期列线图一致性指数为0.752(95%CI:0.741-0.764)。
  • 训练队列中肿瘤特异性生存期列线图一致性指数为0.753(95%CI:0.741-0.765)。
  • 校准曲线和决策曲线分析显示列线图具有相当的一致性和满意的临床效用。
  • 基于列线图将间变性星形细胞瘤患者分为高风险组和低风险组,并构建了总生存期和肿瘤特异性生存期的风险分层系统。

临床怎么用

  • 作者认为这些模型可能有助于未来临床实践。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Anaplastic astrocytoma (AA) is an uncommon primary brain tumor with highly variable clinical outcomes. Our study aimed to develop practical tools for clinical decision-making in a population-based cohort study. METHODS: Data from 2997 patients diagnosed with AA between 2004 and 2015 were retrospectively extracted from the Surveillance, Epidemiology, and End Results database. The Least Absolute Shrinkage and Selection Operator and multivariate Cox regression analyses were applied to select factors and establish prognostic nomograms. The discriminatory ability of these nomogram models was evaluated using the concordance index and receiver operating characteristic curve. Risk stratifications were established based on the nomograms. RESULTS: Selected 2997 AA patients were distributed into the training cohort (70%, 2097) and the validation cohort (30%, 900). Age, household income, tumor site, extension, surgery, radiotherapy, and chemotherapy were identified as independent prognostic factors for both overall survival (OS) and cancer-specific survival (CSS). In the training cohort, our nomograms for OS and CSS exhibited good predictive accuracy with concordance index values of 0.752 (95% CI: 0.741-0.764) and 0.753 (95% CI: 0.741-0.765), respectively. Calibration and decision curve analyses curves showed that the nomograms demonstrated considerable consistency and satisfactory clinical utilities. With the establishment of nomograms, we stratified AA patients into high- and low-risk groups, and constructed risk stratification systems for OS and CSS. CONCLUSIONS: We constructed two predictive nomograms and risk classification systems to effectively predict the OS and CSS rates in AA patients. These models were internally validated with considerable accuracy and reliability and might be helpful in future clinical practices.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Mei Q, Shen H, Chai X, et al. Practical Nomograms and Risk Stratification System for Predicting the Overall and Cancer-specific Survival in Patients with Anaplastic Astrocytoma. World Neurosurg. 2024. PMID: 38909753. doi:10.1016/j.wneu.2024.06.076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。